Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
The Role of Antiplatelet agents in ischemic events
View through CrossRef
Antiplatelet treatment could be a key in pharmacological treatment for avoidance of coronary heart disease (CHD) and stroke. Depending on sign, term of antiplatelet monotherapy or double treatment is shifted. Antiplatelet treatment is shown to avoid a repeat of cardiovascular occasion, in any case, expanded term of dual antiplatelet treatment (DAPT) related with expanded hazard of bleeding. Unstable angina happens due to partially or totally block of the blood coronary blood vessel driving to coronary ischaemia. Intense coronary infection happens due to drawn out coronary ischaemia which causes coronary diseases.
Keywords: dual antiplatelet treatment (DAPT), coronary heart disease (CHD) and stroke.
Society of Pharmaceutical Tecnocrats
Title: The Role of Antiplatelet agents in ischemic events
Description:
Antiplatelet treatment could be a key in pharmacological treatment for avoidance of coronary heart disease (CHD) and stroke.
Depending on sign, term of antiplatelet monotherapy or double treatment is shifted.
Antiplatelet treatment is shown to avoid a repeat of cardiovascular occasion, in any case, expanded term of dual antiplatelet treatment (DAPT) related with expanded hazard of bleeding.
Unstable angina happens due to partially or totally block of the blood coronary blood vessel driving to coronary ischaemia.
Intense coronary infection happens due to drawn out coronary ischaemia which causes coronary diseases.
Keywords: dual antiplatelet treatment (DAPT), coronary heart disease (CHD) and stroke.
Related Results
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Single vs Double Antiplatelet Therapy for Recurrent Ischemic Stroke Prevention
Single vs Double Antiplatelet Therapy for Recurrent Ischemic Stroke Prevention
Background: Ischemic stroke remains a leading cause of mortality and long-term disability, with recurrent events contributing significantly to the global disease burden. While sing...
Clinical Role of Microembolic Signals in Adult Moyamoya Disease With Ischemic Stroke
Clinical Role of Microembolic Signals in Adult Moyamoya Disease With Ischemic Stroke
Background and Purpose—
Hemodynamic compromise has been implicated in moyamoya disease (MMD) with transient ischemic attacks or ischemic stroke. However, increasing evi...
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
According to epidemiological studies, the leading cause of morbidity, disability and mortality are cerebrovascular diseases, in particular ischemic and hemorrhagic strokes. In rece...
PERIOPERATIVE MANAGEMENT OF INDIVIDUALS WITH ANTICOAGULANT AND ANTIPLATELET THERAPY
PERIOPERATIVE MANAGEMENT OF INDIVIDUALS WITH ANTICOAGULANT AND ANTIPLATELET THERAPY
Introduction: The increased use of anticoagulant therapy and antiplatelet therapy requires careful management, especially in patients requiring surgery. These treatments include or...
Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study
Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study
Abstract
Background
Atherogenic index of plasma (AIP) has been demonstrated as a surrogate marker for ischemic stroke, but there is limited evidence...
Dual Antiplatelet Therapy Role in Acute Ischemic Stroke
Dual Antiplatelet Therapy Role in Acute Ischemic Stroke
Stroke is the second greatest cause of mortality and one of the top causes of long-term disability. The fatality rate and age-adjusted prevalence of stroke have decreased globally ...
GW24-e1373 Effect and security with triple antiplatelet therapy in patients undergoing drug-eluting stents for the treatment of complex coronary lesions
GW24-e1373 Effect and security with triple antiplatelet therapy in patients undergoing drug-eluting stents for the treatment of complex coronary lesions
Objectives
To evaluate the efficacy and safety of triple antiplatelet therapy (cilostazol combined with clopidogrel and aspirin) in patients undergoing multiple d...